Pupillometry for the Prediction of Neurologic Outcomes in Severe Traumatic Brain Injury
1 other identifier
observational
74
1 country
1
Brief Summary
Traumatic brain injury (TBI) is a major cause of morbidity and mortality in the US. The CDC states that 1.7 million people sustain a traumatic brain injury each year, with death occurring in 52,000 of these injured patients. It is also estimated that 275,000 yearly require hospitalization. The costs of TBI can be devastating to our society, with the 2010 economic cost estimated to be approximately $76.5 billion. 90% of this cost involves fatal or hospitalized brain injured patients. Furthermore, survivors of traumatic brain injury have high rates of institutionalization, readmission, and disability. The prediction of prognosis in severe TBI is a difficult problem for physicians. Prognosis evaluation in the acute phase of care varies widely among physicians caring for these patients\[3\]. With prognosis often in doubt, physicians have difficulty leading families and patients toward the most appropriate treatment which often leads to expensive testing and patient management. The Brain Trauma Foundation has recommended several early indicators of prognosis in severe TBI, including age, hypotension, CT scan features, Glasgow Outcome Scale score, and pupillary diameter with light reflexes. Pupillary diameter and light reflexes have been extensively studied, however accurate measurements of these prognostic factors have not been performed due to a lack of standardized measuring procedure. A new device has been validated to measure both pupil size and reactivity using infrared pupillometry. This device has also been studied to create the Neurological Pupil Index (NPi) as a measure of pupillary reactivity. The NPi has been shown to correlate with intracranial pressure readings, however there are no studies correlating the pupillometer findings with outcome measures in TBI. This study will prospectively evaluate the pupillometer readings of pupillary size and reactivity (NPi) to test the hypothesis that the NPi is a realiable predictor of 30-day outcomes in patients with severe TBI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 1, 2015
CompletedFirst Posted
Study publicly available on registry
June 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedSeptember 28, 2016
September 1, 2016
3 years
June 1, 2015
September 27, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Functional Independence Measure + Functional Assessment Measure (FIM + FAM)
The FIM/FAM is a single outcome measure. The FAM is an adjunct to the FIM and is not meant to stand alone as an assessment measure.
Time of discharge from ICU, which is typically a duration of 2-3 weeks
Secondary Outcomes (6)
Survival
Patients will be followed for duration of hospital stay, typically a duration of 2-3 weeks, but potentially longer in the case of more severe cases
Time to discharge from acute care facility
Patients will be followed for duration of hospital stay, typically a duration of 2-3 weeks, but potentially longer in the case of more severe cases
Time to discharge to home
Patients will be followed for duration of hospital stay, typically a duration of 2-3 weeks, but potentially longer in the case of more severe cases
FIM + FAM at 30, 60, and 90 days post injury
30, 60, and 90 days post injury
Activities of daily living (ADL)
90 days post injury
- +1 more secondary outcomes
Study Arms (2)
NPi greather than 3
All patients will undergo initial pupillometry evaluation with recording of the NPi in the initial evaluation in the emergency department as per standard evaluation of all trauma patients. If pupils are unequal, group assignment will be determined by lowest pupil reading. Patients with an NPi greater than 3 will be assigned to this group. Pupillometry readings will be gathered for the first 7 days of hospital admission or until discharge. 30, 60, and 90 day post-injury outcomes will be collected.
NPi less than or equal to 3
All patients will undergo initial pupillometry evaluation with recording of the NPi in the initial evaluation in the emergency department as per standard evaluation of all trauma patients. If pupils are unequal, group assignment will be determined by lowest pupil reading. Patients with an NPi less than or equal to 3 will be assigned to this group. Pupillometry readings will be gathered for the first 7 days of hospital admission or until discharge. 30, 60, and 90 day post-injury outcomes will be collected.
Eligibility Criteria
Adult trauma patients age 18 years or older with evidence of traumatic brain injury and intubated requiring mechanical ventilation.
You may qualify if:
- Adult patients 18 years of age or older
- Presence of subdural hematoma (SDH), subarachnoid hemorrhage (SAH), epidural hematoma (EDH) or intracerebral hemorrhage (ICH), or cerebral contusion resultant from traumatic brain injury
- Intubated requiring mechanical ventilation
You may not qualify if:
- Unable to obtain initial pupillometer reading within six (6) hours of traumatic insult
- History of blindness or enucleation of one or both eyes
- Traumatic injury to one or both eyes such that pupillometry is not possible
- Previous history of known Third Cranial Nerve palsy
- Administration of IV or topical atropine within 6 hours of first pupillometer reading
- Unwilling or unable to consent (or unable to find an appropriate surrogate)
- Pregnant
- History of severe dementia or neurodegenerative disease, mental illnesses requiring long-term institutionalization, severe neuromuscular disorders (Parkinson's disease, Huntington's disease), previous structural brain defect either congenital or due to previous trauma or medical disease, previous anoxic brain injury
- Expected death within 24 hours of enrollment, or desire by patient of family to pursue palliative rather than aggressive, supportive care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, 70808, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Danielle Tatum, Ph.D.
Our Lady of the Lake Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Academic Research Director
Study Record Dates
First Submitted
June 1, 2015
First Posted
June 8, 2015
Study Start
September 1, 2014
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
September 28, 2016
Record last verified: 2016-09